T45.7X2 类别:需要更具体的编码 Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm
ICD-10-CM T45.7X2 identifies “Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
章节 19: Injury, poisoning and certain other consequences of external causes
编码说明
无额外说明。
上级编码说明
章节 19 · Injury, poisoning and certain other consequences of external causes (S00-T88)
Excludes 22
- birth trauma (P10-P15)
- obstetric trauma (O70-O71)
Use additional code1
code to identify any retained foreign body, if applicable (Z18.-)
Note2
- Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
- The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.
T36-T50 · Poisoning by, adverse effects of and underdosing of drugs, medicaments and biological substances (T36-T50)
Includes4
- adverse effect of correct substance properly administered
- poisoning by overdose of substance
- poisoning by wrong substance given or taken in error
- underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed
Excludes 11
toxic reaction to local anesthesia in pregnancy (O29.3-)
Excludes 25
Code first7
Use additional code4
Note1
The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
T45 · Poisoning by, adverse effect of and underdosing of primarily systemic and hematological agents, not elsewhere classified
Seventh character1
The appropriate 7th character is to be added to each code from category T45
A — initial encounter
D — subsequent encounter
S — sequela
更具体的编码
T45.7X2APoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, initial encounter可计费的具体编码T45.7X2DPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, subsequent encounter可计费的具体编码T45.7X2SPoisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm, sequela可计费的具体编码官方索引引用
官方索引引用 (36)
Acetomenaphthone (1)
- Acetomenaphthone药物和化学物质
Antagonist (1)
- Antagonist › anticoagulant药物和化学物质
Anticoagulant NEC (1)
Antihemophilic (2)
Antiheparin drug (1)
- Antiheparin drug药物和化学物质
Coagulant NEC (1)
- Coagulant NEC药物和化学物质
Cotarnine (1)
- Cotarnine药物和化学物质
Cytozyme (1)
- Cytozyme药物和化学物质
Etamsylate (1)
- Etamsylate药物和化学物质
Ethamsylate (1)
- Ethamsylate药物和化学物质
Factor (1)
- Factor › IX complex药物和化学物质
Gelatin(intravenous) (1)
Gelfoam (1)
- Gelfoam药物和化学物质
Heparin(sodium) (1)
Hexadimethrine(bromide) (1)
- Hexadimethrine(bromide)药物和化学物质
Menadiol (2)
- Menadiol药物和化学物质
- Menadiol › sodium sulfate药物和化学物质
Menadione (2)
- Menadione药物和化学物质
- Menadione › sodium bisulfite药物和化学物质
Menaphthone (1)
- Menaphthone药物和化学物质
Menaquinone (1)
- Menaquinone药物和化学物质
Menatetrenone (1)
- Menatetrenone药物和化学物质
Phylloquinone (1)
- Phylloquinone药物和化学物质
Phytomenadione (1)
- Phytomenadione药物和化学物质
Phytonadione (1)
- Phytonadione药物和化学物质
Protamine sulfate (1)
- Protamine sulfate药物和化学物质
Prothrombin (1)
- Prothrombin › activator药物和化学物质
Russel's viper venin (1)
- Russel's viper venin药物和化学物质
Snake venom or bite (1)
Sponge, absorbable(gelatin) (1)
- Sponge, absorbable(gelatin)药物和化学物质
Thrombin (1)
- Thrombin药物和化学物质
Thromboplastin (1)
- Thromboplastin药物和化学物质
Vitamin NEC (3)
- Vitamin NEC › K NEC药物和化学物质
- Vitamin NEC › K1药物和化学物质
- Vitamin NEC › K2药物和化学物质
历史
编码历史
最近记录的变更 · FY2025 · 04-01
生效日期
- 上级说明变更
Poisoning by anticoagulant antagonists, vitamin K and other coagulants, intentional self-harm
类别 — 请选择更具体的编码
CDC/NCHS · FY2025 · 04-01所有版本 (19)
| 所有版本 | 生效日期 | 编码历史 |
|---|---|---|
| FY2016 | 2015-10-01 | 首次收录 |
| FY2017 | 2016-10-01 | 分类表无变更 |
| FY2018 | 2017-10-01 | 分类表无变更 |
| FY2019 | 2018-10-01 | 上级说明变更 |
| FY2020 | 2019-10-01 | 分类表无变更 |
| FY2020 · April | 2020-04-01 | 分类表无变更 |
| FY2021 | 2020-10-01 | 上级说明变更 |
| FY2021 · 01-01 | 2021-01-01 | 分类表无变更 |
| FY2022 | 2021-10-01 | 分类表无变更 |
| FY2022 · 04-01 | 2022-04-01 | 分类表无变更 |
| FY2023 | 2022-10-01 | 分类表无变更 |
| FY2023 · 04-01 | 2023-04-01 | 分类表无变更 |
| FY2024 | 2023-10-01 | 分类表无变更 |
| FY2024 · 04-01 | 2024-04-01 | 分类表无变更 |
| FY2025 | 2024-10-01 | 分类表无变更 |
| FY2025 · 04-01 | 2025-04-01 | 上级说明变更 |
| FY2026 | 2025-10-01 | 分类表无变更 |
| FY2026 · April | 2026-04-01 | 分类表无变更 |
| FY2027 | 2026-10-01 | 分类表无变更 |
浏览此类别中更具体的编码。 参考核验不能确定临床适用性,也不保证报销。